Who owns Y Mabs Therapeutics Inc?
- Ticker: YMAB
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Paradigm Biocapital Advisors | 4.2M | $19M | 0% | Mar 2025 |
|
Acorn Capital Advisors | 3.2M | $14M | 13% | Mar 2025 |
|
BlackRock | 2.9M | $13M | -3% | Mar 2025 |
|
Caligan Partners | 2.3M | $10M | 33% | Mar 2025 |
|
Sofinnova Ventures | 2.2M | $9.7M | 0% | Mar 2025 |
|
Vanguard Group | 1.9M | $8.6M | -3% | Mar 2025 |
|
Geode Capital Management | 850k | $3.8M | 3% | Mar 2025 |
|
State Street Corporation | 789k | $3.5M | -40% | Mar 2025 |
|
Boothbay Fund Management | 694k | $3.1M | 0% | Mar 2025 |
|
D. E. Shaw & Co | 550k | $2.4M | -11% | Mar 2025 |
|
Millennium Management | 467k | $2.1M | 1216% | Mar 2025 |
|
Pictet Asset Management Holding SA | 442k | $2.0M | -42% | Mar 2025 |
|
Dimensional Fund Advisors | 419k | $1.9M | -10% | Mar 2025 |
|
Northern Trust | 328k | $1.5M | -9% | Mar 2025 |
|
Charles Schwab Investment Management | 278k | $1.2M | -2% | Mar 2025 |
|
Renaissance Technologies | 257k | $1.1M | 95% | Mar 2025 |
|
Jpmorgan Chase & Co | 247k | $1.1M | 153% | Mar 2025 |
|
Jacobs Levy Equity Management | 238k | $1.1M | 59% | Mar 2025 |
|
Wellington Management Company | 204k | $904k | 53% | Mar 2025 |
|
Goldman Sachs Group | 202k | $894k | -8% | Mar 2025 |
|
Citadel Advisors | 195k | $861k | -15% | Mar 2025 |
|
AQR Capital Management | 165k | $730k | 869% | Mar 2025 |
|
Infinitum Asset Management | 156k | $689k | 0% | Mar 2025 |
|
Cubist Systematic Strategies | 156k | $689k | 224% | Mar 2025 |
|
Two Sigma Investments | 155k | $686k | 75% | Mar 2025 |
|
Federated Investors | 154k | $680k | 245% | Mar 2025 |
|
Two Sigma Advisers | 143k | $635k | 94% | Mar 2025 |
|
Stonepine Capital Management | 131k | $581k | 100% | Mar 2025 |
|
Squarepoint Ops | 129k | $569k | 25% | Mar 2025 |
|
Nuveen | 113k | $498k | 100% | Mar 2025 |
|
Rice Hall James & Associates | 104k | $459k | -5% | Mar 2025 |
|
Bnp Paribas Arbitrage, Snc | 96k | $423k | 1859% | Mar 2025 |
|
Bank of New York Mellon | 93k | $410k | 0% | Mar 2025 |
|
UBS Group | 92k | $406k | 135% | Mar 2025 |
|
XTX Topco | 92k | $405k | 340% | Mar 2025 |
|
Susquehanna International | 61k | $269k | 113% | Mar 2025 |
|
Alliancebernstein | 55k | $243k | 0% | Mar 2025 |
|
Rhumbline Advisers | 54k | $239k | 5% | Mar 2025 |
|
Barclays | 47k | $207k | -38% | Mar 2025 |
|
Sapient Capital | 44k | $197k | 0% | Jun 2025 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 43k | $192k | 0% | Mar 2025 |
|
Quest Partners | 39k | $172k | 43% | Mar 2025 |
|
Virtus Investment Advisers | 37k | $163k | 100% | Mar 2025 |
|
ALPS Advisors | 33k | $148k | -8% | Mar 2025 |
|
Invesco | 33k | $144k | 118% | Mar 2025 |
|
Point72 Asia | 31k | $138k | 100% | Mar 2025 |
|
FMR | 29k | $130k | -43% | Mar 2025 |
|
Deutsche Bank Aktiengesellschaft | 29k | $128k | -11% | Mar 2025 |
|
Citigroup | 29k | $127k | -42% | Mar 2025 |
|
Intech Investment Management | 27k | $118k | 20% | Mar 2025 |
|
Man Group | 26k | $115k | 100% | Mar 2025 |
|
Bridgeway Capital Management | 25k | $110k | -50% | Mar 2025 |
|
Principal Financial Group | 22k | $99k | 1% | Mar 2025 |
|
Mirae Asset Global Etfs Holdings | 22k | $98k | -3% | Mar 2025 |
|
GSA Capital Partners | 21k | $91k | 100% | Mar 2025 |
|
Corebridge Financial | 18k | $81k | -1% | Mar 2025 |
|
Wells Fargo & Company | 18k | $79k | 2% | Mar 2025 |
|
MetLife Investment Advisors | 17k | $76k | -23% | Mar 2025 |
|
Florida State Board of Administration | 15k | $65k | 0% | Mar 2025 |
|
Bayesian Capital Management | 14k | $64k | 100% | Mar 2025 |
|
Manufacturers Life Insurance Company | 14k | $62k | 1% | Mar 2025 |
|
SG Americas Securities | 13k | $59k | -25% | Mar 2025 |
|
EntryPoint Capital | 13k | $56k | 100% | Mar 2025 |
|
Corton Capital | 12k | $55k | 100% | Mar 2025 |
|
Connor, Clark & Lunn Investment Management | 11k | $49k | 100% | Mar 2025 |
|
Ing Investment Management | 10k | $45k | -13% | Mar 2025 |
|
New York State Common Retirement Fund | 10k | $45k | 0% | Mar 2025 |
|
ProShare Advisors | 10k | $45k | -20% | Mar 2025 |
|
China Universal Asset Management | 9.0k | $40k | -5% | Mar 2025 |
|
Legal & General Group | 8.6k | $38k | -75% | Mar 2025 |
|
Skopos Labs | 5.9k | $26k | 4564% | Mar 2025 |
|
Point72 | 5.1k | $22k | 936% | Mar 2025 |
|
Tower Research Capital | 5.0k | $22k | 206% | Mar 2025 |
|
Lazard Asset Management | 4.8k | $21k | 100% | Mar 2025 |
|
Summit Investment Advisors | 3.7k | $16k | 0% | Mar 2025 |
|
California State Teachers Retirement System | 2.7k | $12k | -91% | Mar 2025 |
|
CWM | 2.4k | $10k | 3356% | Mar 2025 |
|
Royal Bank of Canada | 1.7k | $7.2k | -97% | Mar 2025 |
|
Mirae Asset Global Investments | 1.5k | $7.2k | 1% | Mar 2025 |
|
Amalgamated Bank | 1.2k | $5.0k | 0% | Mar 2025 |
|
Gf Fund Management | 1.1k | $4.9k | 18% | Mar 2025 |
|
Simplex Trading | 437.00 | $999.987100 | -75% | Mar 2025 |
|
NISA Investment Advisors | 259.00 | $1.1k | 380% | Mar 2025 |
|
Daiwa Securities Group | 162.00 | $999.993600 | 0% | Mar 2025 |
|
Rothschild Investment | 110.00 | $487.003000 | 175% | Mar 2025 |
|
SCBT Financial Corporation | 68.00 | $302.001600 | 100% | Mar 2025 |
|
CoreCap Advisors | 46.00 | $204.000800 | 100% | Mar 2025 |
|
EverSource Wealth Advisors | 44.00 | $194.999200 | 100% | Mar 2025 |
|
Sterling Capital Management | 38.00 | $168.001800 | 0% | Mar 2025 |
|
True Wealth Design | 17.00 | $76.000200 | 100% | Mar 2025 |
|
SBI Securities | 16.00 | $71.000000 | 0% | Mar 2025 |
|
Farther Finance Advisors | 1.00 | $5.000000 | -100% | Jun 2025 |
|
Who sold out of Y Mabs Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cormorant Asset Management | Dec 2024 | 425k | $3.3M |
Franklin Resources | Dec 2024 | 67k | $528k |
Swiss National Bank | Dec 2024 | 60k | $472k |
Wesbanco Trust And Investments | Mar 2025 | 55k | $244k |
Ubs Global Asset Management Americas | Dec 2024 | 52k | $410k |
Marshall Wace | Dec 2024 | 49k | $385k |
Rafferty Asset Management | Dec 2024 | 41k | $323k |
State of Wisconsin Investment Board | Dec 2024 | 38k | $296k |
Virtus ETF Advisers | Dec 2024 | 36k | $280k |
Jane Street | Dec 2024 | 33k | $260k |
Engineers Gate Manager | Dec 2024 | 27k | $214k |
Exchange Traded Concepts | Mar 2025 | 27k | $119k |
Prudential Financial | Dec 2024 | 19k | $146k |
Campbell & Co. Investment Adviser | Dec 2024 | 18k | $140k |
Henderson Group | Dec 2024 | 16k | $128k |
Zurcher Kantonalbank | Dec 2024 | 3.3k | $26k |
Great-West Life Assurance Company | Dec 2024 | 3.0k | $24k |
Point72 Asset Management | Dec 2024 | 550.00 | $4.3k |
Bessemer | Dec 2024 | 180.00 | $1.0k |
Us Bancorp | Dec 2024 | 23.00 | $180.000300 |